- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma - Abstract
September 9, 2013
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN - Abstract
September 6, 2013
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies - Abstract
September 6, 2013
Prognostic role of pancreatic metastases from renal cell carcinoma: Results from an Italian center - Abstract
September 6, 2013
Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors - Abstract
September 5, 2013
Is there a benefit to frozen section analysis at the time of partial nephrectomy? - Abstract
September 5, 2013
Tivozanib for the treatment of metastatic renal cancer - Abstract
September 3, 2013
Renal collecting duct carcinoma: Report of a case with unusual imaging findings regarding renal function - Abstract
September 3, 2013
Tivozanib in the treatment of renal cell carcinoma - Abstract
September 3, 2013
Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example - Abstract
September 2, 2013
Germline PTEN mutation Cowden syndrome: An under-appreciated form of hereditary kidney cancer - Abstract
September 2, 2013
Hereditary syndromes with associated renal neoplasia: A practical guide to histologic recognition in renal tumor resection specimens - Abstract
September 2, 2013
Management of localized and locally advanced renal tumors. A contemporary review of current treatment options - Abstract
August 30, 2013